Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-25-015784

Director acquired 3,173 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Quart Barry D Director 2025-06-05 Option exercise +3,173 12,546 D
Derivatives
Quart Barry D Director 2025-06-03 Grant or award · Share Option +16,798 16,798 D
Quart Barry D Director 2025-06-03 Grant or award · Restricted Share Units +2,799 2,799 D
Quart Barry D Director 2025-06-05 Option exercise · Restricted Share Units −3,173 0 D
Loading xslF345X05/form4-06052025_080657.xml…